ArticleFrontiers in medicine2025
Cognitive function and uric acid levels among low-income rural Chinese aged ≥60 years without hyperuricemia.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the association between uric acid (UA) levels and cognitive function in a low-income, rural population in Chinese adults aged ≥60 years without hyperuricemia. Methods: Elderly individuals (≥60 years old) without hyperuricemia from rural areas of Tianjin were included in this cross-sectional study. Basic demographic and clinical information were collected, and cognitive impairment was assessed using the Mini-Mental State Examination (MMSE). Binary logistic regression analysis was performed to evaluate the association between UA levels and cognitive impairment, and multivariate linear regression analysis was used to explore the relationship between UA levels and MMSE scores. Subgroup analyses were conducted based on gender and age. Results: A total of 1,418 participants were included, with 43.1% showing cognitive impairment. Multivariate analysis revealed that the risk of cognitive impairment decreased by 0.2% for each unit increase in UA level and was reduced by 33% in the third quartile of UA levels compared with the lowest quartile (OR = 0.67, 95% CI: 0.49, 0.92, Conclusion: This study highlights the cognitive protective effect of UA in low-income rural Chinese populations aged ≥60 years without hyperuricemia, particularly in men and those aged 60-69 years. These findings underscore the importance of targeted interventions and health education programs to prevent cognitive decline in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.